SCHEMBL4538508

SCHEMBL4538508

CN(C)c1ccc(-n2cccc2C(=O)O)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
POLB P06746 1/20 0.47
APEX1 P27695 1/20 0.47
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MAPK1 P28482 1/20 0.39
AVPR2 P30518 2/20 0.38
NPY2R P49146 1/20 0.37
EPHB3 P54753 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
HPGD P15428 1/20 0.34
P2RX4 Q99571 1/20 0.34
BAZ2B Q9UIF8 1/20 0.34
BAZ2A Q9UIF9 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4543897 0.81 POLB (0.50) L3MBTL1TDP1POLBAPEX1KMT2A
SCHEMBL4540024 0.81 POLB (0.53) L3MBTL1TDP1POLBAPEX1KMT2A
SCHEMBL4540121 0.80 TDP1 (0.43) L3MBTL1TDP1POLBAPEX1KMT2A
SCHEMBL4543912 0.77 LMNA (0.49) L3MBTL1TDP1POLBAPEX1ALDH1A1
SCHEMBL4543294 0.76 TDP1 (0.67) L3MBTL1TDP1POLBAPEX1KMT2A
SCHEMBL4542122 0.75 CYP1A2 (0.47) L3MBTL1TDP1POLBAPEX1KMT2A
SCHEMBL4540551 0.72 POLB (0.50) L3MBTL1TDP1POLBAPEX1KDM4E
SCHEMBL4543812 0.72 CNR2 (0.46) POLBLMNATP53MAPT
SCHEMBL4658534 0.69 POLB (0.53) L3MBTL1TDP1POLBAPEX1KMT2A
SCHEMBL17142873 0.69 SMN1; SMN2 (0.57) POLBKMT2AMEN1AVPR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed